Filing summary
Entity and period mismatch: The supplied filing is Dataram Corporation’s Form 10-K, not a filing by U.S. Gold Corp. It covers the fiscal year ended April 30, 2016, rather than 2015 Q4. The filing describes a proposed acquisition of U.S. Gold as a subsequent event.
Business context and reporting period
Dataram manufactured and sold memory products and related performance solutions through four business lines. Its markets included OEMs, distributors, resellers and end users; DRAM chip prices and availability materially affect product costs and margins. The fiscal 2016 comparison is with the year ended April 30, 2015. Financial statement amounts below are in millions unless noted otherwise; share and per-share amounts reflect the subsequent 1-for-3 reverse split.
Key financial metrics
| Metric | FY ended Apr. 30, 2016 | FY ended Apr. 30, 2015 |
|---|---|---|
| Revenue | $25.182 | $28.258 |
| Gross profit and margin | $4.718; 18.7% | $4.190; 14.8% |
| Operating loss | $(1.240) | $(2.749) |
| Net loss | $(1.221) | $(3.829) |
| Net loss per common share | $(1.07) | $(6.60) |
| Net cash used in operations | $(0.489) | $(2.581) |
| Cash at year-end | $0.056 | $0.327 |
| Total assets | $5.751 | $6.275 |
| Total liabilities | $2.859 | $4.158 |
| Stockholders’ equity | $2.892 | $2.117 |
At April 30, 2016, current assets were $4.261 million and current liabilities were $2.752 million. Revolving-credit borrowings were $1.776 million, secured by substantially all company assets; the facility had a $3.5 million maximum but no additional availability at year-end. The weighted-average borrowing rate was 8.5%. The facility was due to mature November 30, 2016 unless renewed or terminated earlier.
Cash from financing activities was $0.239 million in FY2016, including $0.500 million from common-share sales and $0.100 million from preferred-share sales, offset by net repayments on the credit line and convertible notes. Separately, the company exchanged approximately $0.672 million of notes and accrued interest for Series B preferred equity.
Material changes versus the prior comparable period
- Revenue declined 11%, chiefly after exiting an unprofitable AMD consumer-memory line and reducing sales resources for a marginally profitable broker line.
- Gross margin improved to 18.7% from 14.8%, with lower-cost product mix and cost reductions. Management cited approximately $0.470 million in annualized manufacturing-overhead savings and $1.1 million in annualized SG&A savings.
- Engineering expense fell to $0.191 million from $0.768 million, primarily because a software-development project was suspended in January 2015. SG&A declined to $5.767 million from $6.171 million; FY2016 included $0.746 million of stock-based compensation.
- Other expense decreased to $0.168 million from $1.077 million, mainly because FY2015 included $0.750 million of non-cash debt-discount amortization. FY2016 also recorded a $0.190 million gain on sale of state net operating losses and a $0.022 million debt-extinguishment gain.
- Inventory decreased by $0.753 million, while accounts receivable increased by approximately $0.741 million in operating cash-flow reconciliation, primarily reflecting shipments near year-end.
- Backlog rose to $0.274 million from $0.098 million, but orders are generally cancellable and may not convert to revenue.
Outlook, risks, contingencies and unusual items
- Going concern: The auditor’s report and management disclosures state that recurring losses and the need for additional capital raise substantial doubt about Dataram’s ability to continue as a going concern. The company said it could require up to $1.0 million of working capital over the next 12 months and gave no assurance funding would be available on favorable terms.
- Financing and dilution: The company had minimal cash and no unused availability under its secured revolving facility at year-end. Series B preferred stock was convertible into approximately 2.21 million common shares before ownership and exchange limitations; the filing also describes restrictions on future capital-raising securities and debt without certain preferred-holder consent.
- NASDAQ compliance: The company had received notice of a minimum-bid-price deficiency and reported equity only modestly above the $2.5 million continued-listing threshold. A 1-for-3 reverse split took effect in July 2016 to address the bid-price requirement; future compliance was not assured.
- Proposed U.S. Gold transaction: Dataram entered into a merger agreement on June 13, 2016, amended and restated July 29, 2016. Closing conditions included shareholder approvals, at least $3 million of net proceeds from a U.S. Gold financing, acquisition of the Keystone claims, and a fairness opinion. The merger consideration included substantial potential Dataram share issuance. The filing does not establish that the transaction closed.
- Other risks: DRAM price and supply volatility, intense competition and pricing pressure, dependence on major customers (two customers represented about 20% and 15% of revenue in FY2016), foreign-currency exposure without hedging, and potential funding constraints. The company also disclosed consolidated state-court disputes and employment-related complaints; any potential loss was not estimable.
- Management commentary: Management emphasized cost containment and reduced cash burn but provided no quantified revenue or earnings guidance. It expected existing backlog to be filled during FY2017, mostly in the first quarter.
Most important facts an investor should verify
- Confirm the intended issuer and period: the provided document is Dataram’s FY2016 10-K, not U.S. Gold’s 2015 Q4 filing.
- Check subsequent filings for the status, final terms, financing and closing of the U.S. Gold merger, including the effects of share issuance and preferred-stock conversions.
- Verify current liquidity, facility renewal or replacement, financing availability, and whether the going-concern uncertainty has changed.
- Review NASDAQ listing compliance after the reverse split and the company’s current stockholders’ equity.
- Assess customer concentration, receivable collection, inventory exposure to DRAM pricing, and the status or estimated exposure of the disclosed litigation.